A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases

Improved vaccines and antiviral agents that provide better, broader protection against seasonal and emerging influenza viruses are needed. The viral surface glycoprotein hemagglutinin (HA) is a primary target for the development of universal influenza vaccines and therapeutic antibodies. The other m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuhara, Atsuhiro, Yamayoshi, Seiya, Kiso, Maki, Sakai-Tagawa, Yuko, Okuda, Moe, Kawaoka, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632566/
https://www.ncbi.nlm.nih.gov/pubmed/36329075
http://dx.doi.org/10.1038/s41467-022-34521-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632566/
https://www.ncbi.nlm.nih.gov/pubmed/36329075
http://dx.doi.org/10.1038/s41467-022-34521-0

Ejemplares similares